These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24129370)
1. Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts. Yehia BR; French B; Fleishman JA; Metlay JP; Berry SA; Korthuis PT; Agwu AL; Gebo KA; J Acquir Immune Defic Syndr; 2014 Mar; 65(3):333-9. PubMed ID: 24129370 [TBL] [Abstract][Full Text] [Related]
2. Impact of age on retention in care and viral suppression. Yehia BR; Rebeiro P; Althoff KN; Agwu AL; Horberg MA; Samji H; Napravnik S; Mayer K; Tedaldi E; Silverberg MJ; Thorne JE; Burchell AN; Rourke SB; Rachlis A; Mayor A; Gill MJ; Zinski A; Ohl M; Anastos K; Abraham AG; Kitahata MM; Moore RD; Gebo KA; J Acquir Immune Defic Syndr; 2015 Apr; 68(4):413-9. PubMed ID: 25559604 [TBL] [Abstract][Full Text] [Related]
3. Patient activation and improved outcomes in HIV-infected patients. Marshall R; Beach MC; Saha S; Mori T; Loveless MO; Hibbard JH; Cohn JA; Sharp VL; Korthuis PT J Gen Intern Med; 2013 May; 28(5):668-74. PubMed ID: 23288378 [TBL] [Abstract][Full Text] [Related]
4. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy. Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305 [TBL] [Abstract][Full Text] [Related]
5. Measuring retention in HIV care: the elusive gold standard. Mugavero MJ; Westfall AO; Zinski A; Davila J; Drainoni ML; Gardner LI; Keruly JC; Malitz F; Marks G; Metsch L; Wilson TE; Giordano TP; J Acquir Immune Defic Syndr; 2012 Dec; 61(5):574-80. PubMed ID: 23011397 [TBL] [Abstract][Full Text] [Related]
6. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126 [TBL] [Abstract][Full Text] [Related]
7. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898 [TBL] [Abstract][Full Text] [Related]
8. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. Dombrowski JC; Kitahata MM; Van Rompaey SE; Crane HM; Mugavero MJ; Eron JJ; Boswell SL; Rodriguez B; Mathews WC; Martin JN; Moore RD; Golden MR J Acquir Immune Defic Syndr; 2013 Jul; 63(3):299-306. PubMed ID: 23572013 [TBL] [Abstract][Full Text] [Related]
9. Higher retention and viral suppression with adolescent-focused HIV clinic in South Africa. Zanoni BC; Sibaya T; Cairns C; Lammert S; Haberer JE PLoS One; 2017; 12(12):e0190260. PubMed ID: 29287088 [TBL] [Abstract][Full Text] [Related]
10. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses. Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078 [TBL] [Abstract][Full Text] [Related]
12. The association between cigarette smoking, virologic suppression, and CD4+ lymphocyte count in HIV-Infected Russian women. Brown JL; Winhusen T; DiClemente RJ; Sales JM; Rose ES; Safonova P; Levina O; Belyakov N; Rassokhin VV AIDS Care; 2017 Sep; 29(9):1102-1106. PubMed ID: 28497980 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial evaluating the effects of a family-centered HIV care model on viral suppression and retention in care of HIV-positive children in Eswatini. Ashburn K; Chouraya C; Khumalo P; Mpango L; Mthethwa N; Machekano R; Guay L; Mofenson LM PLoS One; 2021; 16(8):e0256256. PubMed ID: 34428241 [TBL] [Abstract][Full Text] [Related]
14. Postpartum Engagement in HIV Care: An Important Predictor of Long-term Retention in Care and Viral Suppression. Adams JW; Brady KA; Michael YL; Yehia BR; Momplaisir FM Clin Infect Dis; 2015 Dec; 61(12):1880-7. PubMed ID: 26265499 [TBL] [Abstract][Full Text] [Related]
15. High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy. Pasternak AO; de Bruin M; Bakker M; Berkhout B; Prins JM PLoS One; 2015; 10(10):e0140791. PubMed ID: 26468956 [TBL] [Abstract][Full Text] [Related]
16. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. Hunt PW; Deeks SG; Rodriguez B; Valdez H; Shade SB; Abrams DI; Kitahata MM; Krone M; Neilands TB; Brand RJ; Lederman MM; Martin JN AIDS; 2003 Sep; 17(13):1907-15. PubMed ID: 12960823 [TBL] [Abstract][Full Text] [Related]
17. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression. Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A; PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066 [TBL] [Abstract][Full Text] [Related]
18. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. Loutfy MR; Genebat M; Moore D; Raboud J; Chan K; Antoniou T; Milan D; Shen A; Klein MB; Cooper C; Machouf N; Rourke SB; Rachlis A; Tsoukas C; Montaner JS; Walmsley SL; Smieja M; Bayoumi A; Mills E; Hogg RS; J Acquir Immune Defic Syndr; 2010 Dec; 55(4):451-9. PubMed ID: 21105259 [TBL] [Abstract][Full Text] [Related]
19. Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015-6 ZIMPHIA survey. Balachandra S; Rogers JH; Ruangtragool L; Radin E; Musuka G; Oboho I; Paulin H; Parekh B; Birhanu S; Takarinda KC; Hakim A; Apollo T PLoS One; 2020; 15(6):e0230205. PubMed ID: 32584821 [TBL] [Abstract][Full Text] [Related]
20. The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppression. Yehia BR; Stephens-Shields AJ; Fleishman JA; Berry SA; Agwu AL; Metlay JP; Moore RD; Christopher Mathews W; Nijhawan A; Rutstein R; Gaur AH; Gebo KA; PLoS One; 2015; 10(6):e0129376. PubMed ID: 26086089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]